More than half of patients will die within 12 months of the six most fatal cancers, says new data. Here’s how to reduce the risk ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, ...

For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are ...

Our findings highlight divergent trends, such as the global reduction in tobacco-associated mortality but rising mortality linked to ambient particulate matter,” researchers wrote.

The mRNA-4157 cancer vaccine, combined with Keytruda, produced anti-tumor responses in NSCLC and melanoma, indicating potential for neoantigen therapies. SABR is a viable curative treatment for ...

Obesity was associated with improved overall survival (OS) after curative resection in patients with non-small cell lung cancer (NSCLC), particularly those who did not have low sk ...

Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan ...

Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help ...